Combined Administration of (<i>R</i>)-Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Induces Rapid and Sustained Effects in the CUMS Model of Depression via a TrkB/BDNF-Dependent Mechanism.

Rafalo-Ulinska, Anna; Branski, Piotr; Palucha-Poniewiera, Agnieszka

Combined Administration of (R)-Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Induces Rapid and Sustained Effects in the CUMS Model of Depression via a TrkB/BDNF-Dependent Mechanism.

Rafalo-Ulinska, Anna; Branski, Piotr; Palucha-Poniewiera, Agnieszka.

Afiliação

Rafalo-Ulinska A; Department of Neurobiology, Maj Institute of Pharmacology, Polish Academy of Sciences, Smetna Street 12, 31-343 Kraków, Poland.
Branski P; Department of Neurobiology, Maj Institute of Pharmacology, Polish Academy of Sciences, Smetna Street 12, 31-343 Kraków, Poland.
Palucha-Poniewiera A; Department of Neurobiology, Maj Institute of Pharmacology, Polish Academy of Sciences, Smetna Street 12, 31-343 Kraków, Poland.

Pharmaceuticals (Basel) ; 15(2)2022 Jan 21.

Article em En | MEDLINE | ID: mdl-35215237

Palavras-chave

(R)-ketamine; (S)-ketamine; BDNF; CUMS; LY341495; antidepressant

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pharmaceuticals (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Polônia País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google